Overexpression of mouse prion protein in transgenic mice causes a non-transmissible spongiform encephalopathy.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 10 2022
Historique:
received: 19 10 2021
accepted: 29 09 2022
entrez: 13 10 2022
pubmed: 14 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

Transgenic mice over-expressing human PRNP or murine Prnp transgenes on a mouse prion protein knockout background have made key contributions to the understanding of human prion diseases and have provided the basis for many of the fundamental advances in prion biology, including the first report of synthetic mammalian prions. In this regard, the prion paradigm is increasingly guiding the exploration of seeded protein misfolding in the pathogenesis of other neurodegenerative diseases. Here we report that a well-established and widely used line of such mice (Tg20 or tga20), which overexpress wild-type mouse prion protein, exhibit spontaneous aggregation and accumulation of misfolded prion protein in a strongly age-dependent manner, which is accompanied by focal spongiosis and occasional neuronal loss. In some cases a clinical syndrome developed with phenotypic features that closely resemble those seen in prion disease. However, passage of brain homogenate from affected, aged mice failed to transmit this syndrome when inoculated intracerebrally into further recipient animals. We conclude that overexpression of the wild-type mouse prion protein can cause an age-dependent protein misfolding disorder or proteinopathy that is not associated with the production of an infectious agent but can produce a phenotype closely similar to authentic prion disease.

Identifiants

pubmed: 36229637
doi: 10.1038/s41598-022-21608-3
pii: 10.1038/s41598-022-21608-3
pmc: PMC9562354
doi:

Substances chimiques

Prion Proteins 0
Prions 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17198

Subventions

Organisme : Medical Research Council
ID : MC_U123192748
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U123160655
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U123170362
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00024/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00024/6
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00024/3
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

PLoS Pathog. 2013;9(9):e1003643
pubmed: 24086135
Lancet. 2001 Jul 21;358(9277):171-80
pubmed: 11476832
PLoS Pathog. 2010 Jan 22;6(1):e1000736
pubmed: 20107515
Nature. 2013 Sep 5;501(7465):45-51
pubmed: 24005412
Science. 2007 Nov 9;318(5852):930-6
pubmed: 17991853
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):304-9
pubmed: 19073920
Annu Rev Neurosci. 2015 Jul 8;38:87-103
pubmed: 25840008
Sci Rep. 2015 May 07;5:10062
pubmed: 25950908
Biochim Biophys Acta. 2007 Nov;1774(11):1438-50
pubmed: 17936697
J Biol Chem. 2013 Jan 4;288(1):33-41
pubmed: 23168413
Vet Res. 2008 Jul-Aug;39(4):47
pubmed: 18519020
Annu Rev Genet. 2013;47:601-23
pubmed: 24274755
Behav Brain Res. 1998 Sep;95(1):47-54
pubmed: 9754876
Science. 2010 Feb 26;327(5969):1132-5
pubmed: 20110469
Neuropathol Appl Neurobiol. 2010 Dec;36(7):576-97
pubmed: 20880036
Cell. 1994 Jul 1;77(7):967-8
pubmed: 7912659
EMBO J. 2002 Feb 1;21(3):202-10
pubmed: 11823413
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
pubmed: 9811807
J Neurosci. 2008 Dec 3;28(49):13258-67
pubmed: 19052217
Nature. 2015 Jun 25;522(7557):478-81
pubmed: 26061765
Acta Neuropathol. 2010 Feb;119(2):177-87
pubmed: 20052481
PLoS Biol. 2020 Jun 9;18(6):e3000725
pubmed: 32516343
Nature. 2015 Sep 10;525(7568):247-50
pubmed: 26354483
J Biol Chem. 2014 Jul 18;289(29):19841-9
pubmed: 24860095
Emerg Infect Dis. 2013 Nov;19(11):1731-9
pubmed: 24188521
Br Med Bull. 2003;66:43-60
pubmed: 14522848
Nat Med. 1998 Oct;4(10):1157-65
pubmed: 9771749
Top Curr Chem. 2011;305:79-99
pubmed: 21769720
Science. 2015 Aug 7;349(6248):1255555
pubmed: 26250687
Curr Top Microbiol Immunol. 1996;207:95-123
pubmed: 8575209
Cell. 1994 Jan 14;76(1):117-29
pubmed: 8287472
PLoS Pathog. 2015 Jul 02;11(7):e1004953
pubmed: 26135918
Nature. 1995 Dec 21-28;378(6559):779-83
pubmed: 8524411
J Biol Chem. 2022 Aug;298(8):102181
pubmed: 35752366
J Gen Virol. 2009 Mar;90(Pt 3):546-558
pubmed: 19218199
J Gen Virol. 2010 Oct;91(Pt 10):2651-7
pubmed: 20610667
Nature. 2016 Nov 09;539(7628):217-226
pubmed: 27830781
Front Mol Neurosci. 2019 Jul 09;12:169
pubmed: 31338021
EMBO J. 1996 Mar 15;15(6):1255-64
pubmed: 8635458
J Biol Chem. 2010 May 7;285(19):14083-7
pubmed: 20304915
Cell Tissue Res. 2022 Aug 27;:
pubmed: 36028585
J Infect Dis. 2022 Sep 13;226(5):933-937
pubmed: 33502474
Cell. 1993 Jul 2;73(7):1339-47
pubmed: 8100741
Vet Res. 2008 Jul-Aug;39(4):32
pubmed: 18284909
Nature. 2011 Feb 24;470(7335):540-2
pubmed: 21350487
Methods Mol Biol. 2008;459:197-227
pubmed: 18576157
Nat Commun. 2014 Jul 09;5:4347
pubmed: 25005024
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20417-22
pubmed: 19915150
Science. 2004 Jul 30;305(5684):673-6
pubmed: 15286374

Auteurs

Graham S Jackson (GS)

MRC Prion Unit at UCL, UCL Institute of Prion Diseases, Courtauld Building, 33 Cleveland Street, London, W1W 7FF, UK. g.s.jackson@prion.ucl.ac.uk.

Jacqueline Linehan (J)

MRC Prion Unit at UCL, UCL Institute of Prion Diseases, Courtauld Building, 33 Cleveland Street, London, W1W 7FF, UK.

Sebastian Brandner (S)

MRC Prion Unit at UCL, UCL Institute of Prion Diseases, Courtauld Building, 33 Cleveland Street, London, W1W 7FF, UK.
Division of Neuropathology, Queen Square Institute of Neurology, London, WC1N 3BG, UK.

Emmanuel A Asante (EA)

MRC Prion Unit at UCL, UCL Institute of Prion Diseases, Courtauld Building, 33 Cleveland Street, London, W1W 7FF, UK.

Jonathan D F Wadsworth (JDF)

MRC Prion Unit at UCL, UCL Institute of Prion Diseases, Courtauld Building, 33 Cleveland Street, London, W1W 7FF, UK.

John Collinge (J)

MRC Prion Unit at UCL, UCL Institute of Prion Diseases, Courtauld Building, 33 Cleveland Street, London, W1W 7FF, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH